Dr. Dana Ishay-Ronen, MD PhD
Ishay-Ronen’s research group studies cancer cell plasticity and trans-differentiation therapeutic approaches using patient-derived organoids.
Dr. Dana Ishay-Ronen is M.D. from the Medical University of Vienna, Austria and Ph.D. in Cell Biology from the University of Basel, Switzerland. During her Ph.D. Dr. Ishay-Ronen developed a novel therapeutic approach to target aggressive breast cancer cells by forcing their trans-differentiation into non-dividing fat cells. Currently a resident in Oncology, Dr. Ishay-Ronen participates in a physician-scientist program at the Sheba medical center.
Her research focuses on translational research towards the establishment of the trans-differentiation strategy as a treatment approach for cancer patients. Utilizing patient-derived organoid culture methods from cancer and normal tissues, the Ishay-Ronen research group studies regulatory mechanisms of cell plasticity during tumorigenesis and cancer progression.
Contact info:
Dr. Dana Ishay-Ronen, MD PhD
Oncology Institute, Sheba Medical Center
Sheba physician-scientist program
